Autistic Disorder Pipeline Insight Report 2024, Featuring Key Products Tasimelteon, Cariprazine, L1-79, JZP541, AB-2004, RO6953958 and SB-121
22 avr. 2024 11h10 HE
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Autistic Disorder - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...